Desogestrel And Ethinyl Estradiol
Generic Name: desogestrel and ethinyl estradiol
Brand Names:
Desogestrel And Ethinyl Estradiol
Desogestrel and ethinyl estradiol tablets USP 0.15 mg/0.03 mg provide an oral contraceptive regimen of 21 light orange round tablets each containing 0.15 mg desogestrel and 0.03 mg ethinyl estradiol.
Overview
Desogestrel and ethinyl estradiol tablets USP 0.15 mg/0.03 mg provide an oral contraceptive regimen of 21 light orange round tablets each containing 0.15 mg desogestrel and 0.03 mg ethinyl estradiol.
Uses
Indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception.
Dosage
Take one light orange active tablet daily for 21 days, then one green reminder tablet daily for 7 days. Patients should follow either Day 1 or Sunday start regimens as directed by their healthcare provider.
Side Effects
Common effects include nausea, vomiting, breakthrough bleeding, and spotting. Serious conditions include thrombophlebitis, myocardial infarction, pulmonary embolism, and cerebral hemorrhage.
Interactions
Enzyme inducers like rifampicin and St. John's wort may decrease effectiveness. CYP3A4 inhibitors may increase hormone concentrations. Should not be combined with ombitasvir/paritaprevir/ritonavir due to liver enzyme elevation risk.
Warnings
Cigarette smoking increases the risk of serious cardiovascular events from combination oral contraceptive use. This risk increases with age, particularly in women over 35 years of age. Contraindicated in patients with thrombophlebitis, cerebrovascular disease, valvular heart disease, uncontrolled hypertension, current breast cancer, hepatic disease, undiagnosed vaginal bleeding.
Pregnancy
Extensive epidemiological studies have revealed no increased risk of birth defects in women who have used oral contraceptives prior to pregnancy. The medication should be discontinued if pregnancy is confirmed.
Storage
Store at 25 degrees C (77 degrees F); excursions permitted to 15 to 30 degrees C (59 to 86 degrees F).
Frequently Asked Questions
What is Desogestrel And Ethinyl Estradiol used for?▼
Indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception.
What are the side effects of Desogestrel And Ethinyl Estradiol?▼
Common effects include nausea, vomiting, breakthrough bleeding, and spotting. Serious conditions include thrombophlebitis, myocardial infarction, pulmonary embolism, and cerebral hemorrhage.
Can I take Desogestrel And Ethinyl Estradiol during pregnancy?▼
Extensive epidemiological studies have revealed no increased risk of birth defects in women who have used oral contraceptives prior to pregnancy. The medication should be discontinued if pregnancy is confirmed.
What are the important warnings for Desogestrel And Ethinyl Estradiol?▼
Cigarette smoking increases the risk of serious cardiovascular events from combination oral contraceptive use. This risk increases with age, particularly in women over 35 years of age. Contraindicated in patients with thrombophlebitis, cerebrovascular disease, valvular heart disease, uncontrolled hypertension, current breast cancer, hepatic disease, undiagnosed vaginal bleeding.
Related Medications
Azelaic Acid
azelaic acid
11 DESCRIPTION Azelaic Acid Gel, 15%, is an aqueous gel which contains azelaic acid, a naturally-occurring saturated dicarboxylic acid. It is for topical use. Chemically, azelaic acid is 1,7-heptanedicarboxylic acid. The molecular formula for azelaic acid is C9 H16 O4. It has the following structure: Azelaic acid has a molecular weight of 188.22. It is a white, odorless crystalline solid. It is poorly soluble in water at 20°C (0.24%) but freely soluble in boiling water and in ethanol.
Duloxetine Hydrochloride
duloxetine hydrochloride
Serotonin and norepinephrine reuptake inhibitor approved for major depressive disorder, generalized anxiety disorder, diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain.
Dabigatran Etexilate Mesylate
dabigatran etexilate mesylate
11 DESCRIPTION The chemical name for dabigatran etexilate mesylate, a direct thrombin inhibitor, is β-Alanine, N-[[2-[[[4-[[[(hexyloxy)carbonyl]amino]iminomethyl] phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-,ethyl ester, methanesulfonate. The empirical formula is C 34 H 41 N 7 O 5 ∙ CH 4 O 3 S and the molecular weight is 723.86 (mesylate salt), 627.75 (free base). The structural formula is: Dabigatran etexilate mesylate is a yellow-white to yellow powder.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.